TRxADE HEALTH Inc.

NASDAQ: MEDS · Real-Time Price · USD
7.59
0.33 (4.55%)
At close: Sep 20, 2024, 10:00 PM

TRxADE HEALTH Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-18.78M -13.72M -3.91M -5.32M
Depreciation & Amortization
53.36K 1.05M 195.85K 138.91K
Stock-Based Compensation
n/a 257.77K 254.11K 181.16K
Other Working Capital
n/a 114.88K -247.67K 829.04K
Other Non-Cash Items
n/a 4.68M 1.75M 1.53M
Deferred Income Tax
n/a n/a -333.28K -390.08K
Change in Working Capital
n/a 5.66M 437.85K 1.08M
Operating Cash Flow
-13.29M -2.07M -1.53M -2.57M
Capital Expenditures
n/a n/a -450.85K -22.6K
Cash Acquisitions
n/a -344.45K 23K n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
27.55M 68.74K -428.59K n/a
Investing Cash Flow
27.55M -275.72K -427.85K -22.6K
Debt Repayment
n/a 250K n/a -225K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-14.86M n/a n/a n/a
Other Financial Acitivies
-2.72M 1.16M -166.09K 16.82K
Financial Cash Flow
-12.98M 1.41M -35.17K -208.18K
Net Cash Flow
307.78K -942.99K -1.99M -2.8M
Free Cash Flow
-13.29M -2.07M -1.98M -2.59M